Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study

by Maud Lemoine, PhD, Yusuke Shimakawa, PhD, Ramou Njie, PhD, Makie Taal, MSc, Gibril Ndow, MD, Isabelle Chemin, PhD, Sumantra Ghosh, PhD, Harr F Njai, PhD, Adam Jeng, BSc, Amina Sow, PhD, Prof. Coumba Toure-Kane, PhD, Prof. Souleymane Mboup, PhD, Penda Suso, BSc, Saydiba Tamba, Abdullah Jatta, Louise Sarr, MD, Aboubacar Kambi, MD, William Stanger, Bsc, Shevanthi Nayagam, MD, Jessica Howell, PhD, Liliane Mpabanzi, PhD, Prof. Ousman Nyan, MD, Prof. Tumani Corrah, PhD, Prof. Hilton Whittle, PhD, Prof. Simon D Taylor-Robinson, PhD, Prof. Umberto D'Alessandro, PhD, Maimuna Mendy, PhD, Prof. Mark R Thursz, MD
Published 2016-08-01